Metraipolis › archive › dc_229a47218dbb

Novel biomarkers to guide glucocorticoid replacement in primary adrenal insufficiency: a proof-of-concept study using copeptin-derived ratios — Europe PMC PMID:42026386

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42026386
DOI
10.1007/s40618-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-03T07:05:41.260Z
SHA-256 of the archived text
279540e412e67fad21018e5fa4227f93fe6103a57af23f40bb5019975abf6185
Stable URL of this page
https://metraipolis.com/documento/dc_229a47218dbb

How to cite

Novel biomarkers to guide glucocorticoid replacement in primary adrenal insufficiency: a proof-of-concept study using copeptin-derived ratios — Europe PMC PMID:42026386 — Europe PMC (en), https://europepmc.org/article/MED/42026386 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_229a47218dbb (Metraipolis archive dc_229a47218dbb, sha256 279540e412e67fad21018e5fa4227f93fe6103a57af23f40bb5019975abf6185)
BibTeX
@misc{dc229a47218dbb,
  title = {Novel biomarkers to guide glucocorticoid replacement in primary adrenal insufficiency: a proof-of-concept study using copeptin-derived ratios — Europe PMC PMID:42026386},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42026386},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_229a47218dbb; sha256 279540e412e67fad21018e5fa4227f93fe6103a57af23f40bb5019975abf6185},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42026386. Agents can read the archived copy with the MCP tool read_document.